This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

Phascolarctobacterium: NCBI 33024, [genus]

Back to details

| Phascolarctobacterium| Phascolarctobacterium Del Dot et al. 1994

  1. Short-Chain Fatty Acid Production:

    • Phascolarctobacterium is involved in the fermentation of dietary fibers in the colon, producing short-chain fatty acids (SCFAs) as byproducts. SCFAs, such as acetate, propionate, and butyrate, are known to play important roles in gut health.
  2. Butyrate Production:

    • Butyrate, in particular, is of interest because it serves as a major energy source for the cells lining the colon. It has anti-inflammatory properties and is associated with maintaining the health of the colonic epithelium.
  3. Metabolism of Fermentable Substrates:

    • Phascolarctobacterium species are capable of metabolizing various fermentable substrates, including lactate and succinate. The metabolism of these substrates contributes to the production of SCFAs and other metabolites.
  4. Dietary Influence:

    • The abundance and activity of Phascolarctobacterium can be influenced by dietary factors. Diets rich in fiber and plant-based foods provide substrates for the fermentation processes carried out by these bacteria.
  5. Associations with Health Conditions:

    • Changes in the abundance of Phascolarctobacterium have been reported in studies of the gut microbiota in various health conditions. Alterations in the relative abundance of this genus have been associated with conditions such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and metabolic disorders. However, the specific roles of Phascolarctobacterium in these conditions are still being investigated.
  6. Anti-Inflammatory Effects:

    • The production of butyrate by Phascolarctobacterium and other bacteria has been linked to anti-inflammatory effects in the gut. Butyrate is known to modulate immune responses and promote a balanced inflammatory environment in the colon.
  7. Cross-Feeding Interactions:

    • Phascolarctobacterium is involved in cross-feeding interactions within the gut microbiota. This involves the exchange of metabolic byproducts between different bacterial species, contributing to the overall stability and functionality of the microbial community.

Other Sources for more information:

Legend

Phascolarctobacterium impacts on other bacteria of the same rank

R2SlopeTax NameParent Chart
0.3091644346714020.5868470072746277BilophilaParent Taxa
0.301329672336578370.5568259358406067ExiguobacteriumParent Taxa
0.288564175367355350.5627425909042358ButyricimonasParent Taxa
0.283040016889572140.561190128326416VescimonasParent Taxa
0.270868122577667240.5520908236503601SimiaoaParent Taxa
0.26611205935478210.5407301783561707PseudoalteromonasParent Taxa
0.25466823577880860.5745139122009277CloacibacteriumParent Taxa

Other bacteria of the same rank impacting Phascolarctobacterium

R2SlopeTax NameParent Chart
0.264601528644561770.5031829476356506BilophilaParent Taxa

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]